secwatch.observer — SEC 8-K summary
======================================

Issuer:     Structure Therapeutics Inc. (GPCR)
CIK:        0001888886
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001104659-23-105038
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Structure Therapeutics raises ~$300M in private placement for GLP-1 pipeline
----------------------------------------------------------------------------

- Sold 21.6M ordinary shares and 2.4M non-voting ordinary shares at $12.49/share (~$37.47/ADS) for ~$300M gross proceeds.
- Proceeds to fund oral GLP-1R agonist GSBR-1290, next-gen GLP-1/GIPR combo, oral amylin agonist, and operations through at least 2026.
- Closing expected on or about Oct 3, 2023; Jefferies and Leerink act as placement agents with 6% fee.
- Registration statement to be filed within 45 days of closing to register resale of shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1888886/000110465923105038/0001104659-23-105038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1888886/000110465923105038/tm2327162d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-105038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer